$CCEP

Transactions in Own Shares

Coca-Cola Europacific Partners repurchased 258,500 ordinary shares on US and London trading venues from 31 August to 4 September 2026, as part of its EUR 1 billion share buyback programme. The shares were bought at varying prices, with the volume-weighted average price ranging from USD 106.1179 to USD 108.8118 on US venues and GBP 79.1880 to GBP 80.1160 on London venues.

Original reporting
Published Sep 7, 2026, 3:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 7, 2026, 3:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Transactions in Own Shares — source image
Decision brief

The 30-second read

$CCEPBullishMed
01

Why it matters

The tranche adds 258,500 shares to the buyback, reducing outstanding shares and potentially supporting the stock price.

02

Market read

A routine buyback tranche with modest size; may provide short‑term price support for CCEP and influence sector sentiment.

03

What to watch

The tranche size is small relative to the €1 bn programme, and market reaction may be muted.

Relevance 6/10Novelty 6/10Timing: post‑market today

Background

The announcement follows the company's February 2026 launch of a €1 bn share repurchase programme.

Company-level read

Ticker impact

$CCEPBullishMedium confidence
Context

Coca‑Cola Europacific Partners disclosed a fresh buyback tranche of 258,500 shares purchased between 31 Aug and 4 Sep 2026.

Expected impact

Potential modest price lift of 1‑2% over the next few days.

Evidence & confidence

Buyback size is modest relative to the €1 bn programme, but the immediate cancellation of shares can tighten supply.

Market effects

Reinforces confidence in the consumer staples sector and may buoy peer beverage stocks.

Minor positive effect on European consumer goods indices.

Limited to investors tracking large‑cap consumer brands.

Counterpoint

Buybacks may mask underlying growth concerns; investors could await larger strategic moves.

Key entities

  • Coca‑Cola Europacific Partners

    Consumer goods company listed on NASDAQ, Euronext Amsterdam, LSE, and BME.

  • Goldman Sachs & Co. LLC

    Counterparty from which the shares were repurchased.

Related articles

$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.